Treatment outcomes of 651 multidrug-resistant tuberculosis (MDR-TB) patients after the administration of second-line drugs.

<p>The cumulative success rate reveals that patients in the Taiwan MDR-TB Consortium (TMTC) era had a higher probability of treatment success than patients in the pre-TMTC era. Dashed line, pre-TMTC era; solid line, TMTC era; dotted line, 95% confidence interval (<i>p</i><0.001 by the log-rank test).